Cerevel Therapeutics to be Acquired by AbbVie for $8.7 Billion NewsbysupervisorDecember 6, 20231 minute readNo comments
Concerns about the 2024 GOP Presidential Nomination NewsbysupervisorDecember 6, 20232 minute readNo comments
News Palatin Technologies Enters Agreement for Share Issuance Palatin Technologies, a biopharmaceutical company, has recently announced a definitive agreement with an institutional investor regarding the issuance… supervisorOctober 23, 2023 Read More